Journal article
Genetics of apolipoprotein H (beta2-glycoprotein I) and anionic phospholipid binding
Lupus, Vol.7 Suppl 2(2_suppl), pp.S10-13
1998
DOI: 10.1177/096120339800700203
PMID: 9814664
Abstract
Apolipoprotein H (apoH; also known as beta2-glycoprotein I), is an essential cofactor for the binding of certain antiphospholipid antibodies (APA) to anionic phospholipid. The gene coding for apoH is polymorphic, with the occurrence of several common alleles in the general population. This genetically determined variation can effect the binding of apoH to anionic phospholipids and consequently the production of APA. Our group has identified two common mutations at codons 306 (Cys-->Gly) and 316 (Trp-->Ser) in the fifth domain of apoH which affect the binding of apoH to anionic phospholipids (phosphatidylserine or cardiolipin). ApoH from serum samples homozygous for each of these mutations or compound heterozygotes for both mutations showed no binding with anionic phospholipids on ELISA. In vitro mutagenesis and transient expression of these mutations in COS-1 cells followed by cardiolipin binding studies confirmed that Gly306 and Ser316 are causative mutations. Our data indicate that the fifth domain of apoH is essential for anionic phospholipid binding and genetically determined variation in this domain can affect the production of apoH-dependent APA.
Details
- Title: Subtitle
- Genetics of apolipoprotein H (beta2-glycoprotein I) and anionic phospholipid binding
- Creators
- M I Kamboh - University of PittsburghH Mehdi - University of Pittsburgh
- Resource Type
- Journal article
- Publication Details
- Lupus, Vol.7 Suppl 2(2_suppl), pp.S10-13
- DOI
- 10.1177/096120339800700203
- PMID
- 9814664
- ISSN
- 0961-2033
- eISSN
- 1477-0962
- Grant note
- HL 54900 / NHLBI NIH HHS
- Language
- English
- Date published
- 1998
- Academic Unit
- Cardiovascular Medicine; Internal Medicine
- Record Identifier
- 9984359698902771
Metrics
7 Record Views